Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNAC Cartesian Therapeutics

未开盘 10-13 16:00:00 EDT

6.57

-0.42

-6.01%

盘后6.57

+0.000.00%

19:30 EDT

最高7.02	最低6.57	成交量21.86万
今开6.98	昨收6.99	日振幅6.51%
总市值1.99亿	流通市值8,149万	总股本3,026万
成交额144.60万	换手率1.76%	流通股本1,240万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNAC","market":"US","secType":"STK","nameCN":"Cartesian Therapeutics","latestPrice":6.57,"timestamp":1791921600000,"preClose":6.99,"halted":0,"volume":218574,"hourTrading":{"tag":"盘后","latestPrice":6.57,"preClose":6.57,"latestTime":"19:30 EDT","volume":105390,"amount":692413.3,"timestamp":1791934203791,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06008583690987123,"floatShares":12402686,"shares":30255400,"eps":-5.79826,"marketStatus":"未开盘","change":-0.42,"latestTime":"10-13 16:00:00 EDT","open":6.98,"high":7.02,"low":6.565,"amount":1446048.644994,"amplitude":0.065093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.79826,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"listingDate":1466568000000,"exchange":"NASDAQ","adjPreClose":6.99,"preHourTrading":{"tag":"盘前","latestPrice":6.99,"preClose":6.99,"latestTime":"09:19 EDT","volume":45,"amount":316.0500075,"timestamp":1791897584738,"change":0,"changeRate":0,"amplitude":0.008584},"postHourTrading":{"tag":"盘后","latestPrice":6.57,"preClose":6.57,"latestTime":"19:30 EDT","volume":105390,"amount":692413.3,"timestamp":1791934203791,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.573913,"impliedVol":1.4098,"impliedVolPercentile":0.7649},"requestUrl":"/m/hq/s/RNAC","defaultTab":"news","newsList":[{"id":"1153813212","title":"Cartesian Therapeutics：Descartes-08治疗重症肌无力III期Aurora试验数据预计2027年一季度揭晓，BLA计划于2027年中提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1153813212","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153813212?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:25","pubTimestamp":1786015510,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics公司今日披露了其核心管线的最新进展：针对Descartes-08用于治疗重症肌无力的III期Aurora临床试验，关键数据预计将在2027年第一季度出炉。与此同时，该公司计划于2027年年中向监管机构提交生物制品许可申请。Descartes-08作为一种创新的细胞疗法，旨在通过调节免疫系统来改善患者症状。公司方面强调，Aurora试验的顺利推进是验证Descartes-08安全性与有效性的重要里程碑。若试验数据积极，BLA的及时提交将有望加速该疗法上市进程，为患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115331823","title":"Cartesian与Westgene达成协议，将获首付款及潜在里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1115331823","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115331823?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:06","pubTimestamp":1781003204,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics与Westgene公司已签署一项合作协议，根据协议条款，Cartesian将获得一笔可观的首付款。此外，若未来研发达到特定里程碑，该公司还有资格获得额外的潜在付款。这项合作旨在推动相关治疗领域的研发进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151394966","title":"Cartesian Therapeutics与Westgene Biopharma达成战略授权协议，加速体内CAR-T平台在自身免疫疾病领域的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1151394966","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151394966?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:01","pubTimestamp":1781002894,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics宣布与Westgene Biopharma签署了一项战略授权协议，旨在加速其体内CAR-T平台在自身免疫疾病领域的开发进程。该合作将整合双方的技术专长与资源，共同推进创新疗法的研发，以应对当前未满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198052136","title":"Cartesian Therapeutics - 笛卡尔-8 mRNA与Westgene LNP治疗MG的临床试验将于2026年下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1198052136","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198052136?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:01","pubTimestamp":1781002883,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics宣布，其采用笛卡尔-8 mRNA与Westgene LNP技术的重症肌无力（MG）临床试验，预计将于2026年下半年正式启动。这项研究标志着该公司在利用先进mRNA平台开发自身免疫性疾病疗法方面迈出了关键一步。试验的推进有望为重症肌无力患者带来新的治疗希望，并进一步验证其专有技术的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197784486","title":"Cartesian Therapeutics获高达1.5亿美元非稀释性融资 重症肌无力三期Aurora试验顶线数据预计2027年第一季度公布 计划年中提交BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=1197784486","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197784486?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:23","pubTimestamp":1779794611,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics公司宣布，已从K2 HealthVenture获得高达1.5亿美元的非稀释性融资。公司预计，针对重症肌无力的三期Aurora临床试验的顶线数据将在2027年第一季度公布。此外，公司计划在2027年年中提交生物制品许可申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167204719","title":"Cartesian Therapeutics 重症肌无力III期Aurora试验关键数据预计2027年一季度公布 生物制品许可申请计划于2027年中提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1167204719","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167204719?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:01","pubTimestamp":1779793312,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics公司宣布，针对重症肌无力的III期Aurora临床试验的关键顶线数据预计将于2027年第一季度获得。公司计划在此之后，于2027年中期向监管机构提交生物制品许可申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146268785","title":"Cartesian Therapeutics获K2 Healthventures高达1.5亿美元非稀释性融资，预计Aurora三期试验顶线数据于2027年第一季度出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=1146268785","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146268785?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:00","pubTimestamp":1779793225,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics公司已成功获得来自K2 Healthventures的高达1.5亿美元非稀释性融资。与此同时，该公司宣布，其关键的Aurora三期临床试验的顶线数据预计将在2027年第一季度公布。这一系列进展为公司的研发管线提供了重要的资金支持，并标志着其核心疗法在重症肌无力治疗领域的开发进入了关键的数据读出阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157617754","title":"Cartesian Therapeutics首季净亏损达3918.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157617754","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157617754?lang=zh_cn&edition=full","pubTime":"2026-04-30 19:14","pubTimestamp":1777547656,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics最新财报显示，公司第一季度净亏损规模达3918.2万美元。值得关注的是，该季度合作收入录得7.8万美元，这一数据折射出生物科技企业通过合作伙伴关系获取资金支持的典型模式。\n尽管营收规模有限，但合作收入的入账仍为这家专注于RNA技术研发的生物制药公司注入了现金流。在创新药研发周期长、投入大的行业背景下，此类合作往往成为企业维持研发进程的重要支撑。当前业绩表现亦反映出新兴生物技术公司在商业化早期阶段的普遍特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516668789","title":"Cartesian Therapeutics, Inc.盘中异动 快速跳水5.04%报17.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516668789?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:24","pubTimestamp":1741033455,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时24分，Cartesian Therapeutics, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报17.89美元/股，成交量12.1887万股，换手率0.47%，振幅3.42%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4605.74%、213.48%、183.42%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042415a25da197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042415a25da197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516309937","title":"Cartesian Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516309937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516309937?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:32","pubTimestamp":1740774761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时32分，Cartesian Therapeutics, Inc.股票出现异动，股价急速拉升5.19%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Enveric Biosciences, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3274.50%、601.95%、399.87%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301043241a25852d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301043241a25852d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514862712","title":"Cartesian Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514862712?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:37","pubTimestamp":1740602222,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时37分，Cartesian Therapeutics, Inc.股票出现异动，股价大幅下跌5.09%。截至发稿，该股报18.10美元/股，成交量5.3639万股，换手率0.21%，振幅6.48%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6870.06%、346.64%、265.50%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270437029893ec41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270437029893ec41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509728627","title":"Cartesian Therapeutics, Inc.盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509728627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509728627?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:48","pubTimestamp":1738943314,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时48分，Cartesian Therapeutics, Inc.股票出现波动，股价快速下跌5.16%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为4282.50%、149.12%、91.27%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、53.38%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234834a23d34d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234834a23d34d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509349509","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509349509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509349509?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:47","pubTimestamp":1738698456,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时47分，Cartesian Therapeutics, Inc.股票出现波动，股价急速下跌5.44%。截至发稿，该股报18.81美元/股，成交量1.1114万股，换手率0.04%，振幅4.37%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Mink Therapeutics, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1913.83%、984.88%、585.70%，振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Mink Therapeutics, Inc.，振幅分别为123.99%、59.42%、58.02%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205034736a23962a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205034736a23962a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNAC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507658231","title":"Cartesian Therapeutics, Inc.盘中异动 早盘股价大跌6.15%报18.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507658231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507658231?lang=zh_cn&edition=full","pubTime":"2025-01-30 00:15","pubTimestamp":1738167342,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日00时15分，Cartesian Therapeutics, Inc.股票出现异动，股价快速跳水6.15%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为4630.39%、2164.24%、740.32%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Ocean Biomedical, Inc.，振幅分别为185.36%、95.00%、93.15%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013000154298761670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013000154298761670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505067727","title":"Cartesian Therapeutics, Inc.盘中异动 早盘快速下跌6.57%报18.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505067727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505067727?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:05","pubTimestamp":1737561924,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时05分，Cartesian Therapeutics, Inc.股票出现异动，股价快速下跌6.57%。截至发稿，该股报18.55美元/股，成交量1.8574万股，换手率0.07%，振幅3.48%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Immunoprecise Antibodies Ltd.、Dermata Therapeutics Inc C/Wts 、Nutriband Inc C/Wts 涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为884.68%、182.84%、70.99%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.，振幅分别为53.51%、50.39%、47.48%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123000524abb4b9ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123000524abb4b9ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503674850","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘大幅拉升5.94%报19.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503674850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503674850?lang=zh_cn&edition=full","pubTime":"2025-01-16 04:14","pubTimestamp":1736972091,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日04时14分，Cartesian Therapeutics, Inc.股票出现波动，股价大幅拉升5.94%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1095.07%、242.06%、215.18%，振幅较大的相关个股有Os Therapies Incorporated、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为70.43%、68.03%、68.00%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116041451a2234bfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116041451a2234bfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503581013","title":"Cartesian Therapeutics, Inc.盘中异动 股价大涨5.37%报17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503581013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503581013?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:48","pubTimestamp":1736783302,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时48分，Cartesian Therapeutics, Inc.股票出现波动，股价大幅拉升5.37%。截至发稿，该股报17.75美元/股，成交量3.7858万股，换手率0.15%，振幅7.24%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为10011.37%、5565.32%、419.86%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为318.93%、216.61%、124.54%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132348229864e3d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132348229864e3d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501987572","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501987572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501987572?lang=zh_cn&edition=full","pubTime":"2025-01-07 02:24","pubTimestamp":1736187879,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时24分，Cartesian Therapeutics, Inc.股票出现异动，股价急速拉升5.40%。截至发稿，该股报17.76美元/股，成交量11.3862万股，换手率0.45%，振幅7.42%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Scisparc Ltd.、Unity Biotechnology, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1659.99%、378.36%、166.85%，振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为176.15%、106.67%、92.16%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107022439aba0b98b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107022439aba0b98b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500648244","title":"Cartesian Therapeutics, Inc.盘中异动 股价大跌5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500648244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500648244?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:36","pubTimestamp":1735666566,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时36分，Cartesian Therapeutics, Inc.股票出现波动，股价快速下挫5.98%。截至发稿，该股报17.64美元/股，成交量4.7817万股，换手率0.19%，振幅6.61%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，知临集团、Onconetix, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为2793.94%、1836.87%、319.66%，振幅较大的相关个股有Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、知临集团，振幅分别为265.45%、248.39%、204.42%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101013606ab99a3e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101013606ab99a3e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495550514","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘股价大跌5.61%报18.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495550514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495550514?lang=zh_cn&edition=full","pubTime":"2024-12-31 04:19","pubTimestamp":1735589979,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日04时19分，Cartesian Therapeutics, Inc.股票出现波动，股价大幅下挫5.61%。截至发稿，该股报18.68美元/股，成交量5.0189万股，换手率0.20%，振幅3.36%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231041939985569ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231041939985569ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNAC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.selectabio.com","stockEarnings":[{"period":"1week","weight":-0.0267},{"period":"1month","weight":-0.1978},{"period":"3month","weight":-0.2431},{"period":"6month","weight":0.0298},{"period":"1year","weight":-0.3081},{"period":"ytd","weight":-0.0888}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.018},{"period":"3month","weight":0.0307},{"period":"6month","weight":0.1088},{"period":"1year","weight":0.1734},{"period":"ytd","weight":0.1409}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cartesian Therapeutics, Inc.于2007年12月10日在特拉华州成立。该公司是一家临床阶段的公司，开创了治疗自身免疫性疾病的RNA细胞疗法。该公司的主要资产Descartes-08是一种潜在的first-in-class、RNA工程嵌合抗原受体T细胞疗法（rCAR-T），正处于全身性重症肌无力患者的2b期临床开发阶段，并计划在系统性红斑狼疮以及眼部自身免疫和血管性自身免疫篮子试验中开展额外的2期研究。Cartesian在马里兰州盖瑟斯堡经营一家全资拥有的最先进的cGMP生产设施。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.057409},{"month":2,"riseRate":0.6,"avgChangeRate":0.013391},{"month":3,"riseRate":0.4,"avgChangeRate":-0.101096},{"month":4,"riseRate":0.4,"avgChangeRate":-0.078442},{"month":5,"riseRate":0.7,"avgChangeRate":0.161207},{"month":6,"riseRate":0.5,"avgChangeRate":0.087596},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.090833},{"month":8,"riseRate":0.727273,"avgChangeRate":0.067023},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.006009},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.021131},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029903},{"month":12,"riseRate":0.2,"avgChangeRate":-0.107533}],"exchange":"NASDAQ","name":"Cartesian Therapeutics","nameEN":"Cartesian Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cartesian Therapeutics(RNAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cartesian Therapeutics,RNAC,Cartesian Therapeutics股票,Cartesian Therapeutics股票老虎,Cartesian Therapeutics股票老虎国际,Cartesian Therapeutics行情,Cartesian Therapeutics股票行情,Cartesian Therapeutics股价,Cartesian Therapeutics股市,Cartesian Therapeutics股票价格,Cartesian Therapeutics股票交易,Cartesian Therapeutics股票购买,Cartesian Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cartesian Therapeutics(RNAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}